A Corso, A Lorenzi, E Orlandi, C Astori, S Mangiacavalli, M Lazzarino. Advantages of using thalidomide for the management of refractory myeloma patients. haematol [Internet]. 2002Mar.1 [cited 2024Nov.24];87(3):327-8. Available from: https://haematologica.org/article/view/2310